alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
---

EXHIBIT 32.2

CERTIFICATIONS UNDER SECTION 906 OF SARBANES-OXLEY

In connection with the quarterly report of Infolinx
Communications Ltd. (the "Company") on Form 10QSB for the fiscal period ending
May 31, 2008 as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), I, Mark Garfield, Chief Executive Officer of the Company,
certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
of the Sarbanes-Oxley Act of 2002, that:

| | 1. | The Report fully complies with the requirements of
      section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                 
| | 2. | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

|/s/ MARK GARFIELD              | 
|------------------------------ | 
|                               | 
|Name: MARK GARFIELD            | 
|Title: Chief Executive Officer | 
|July 14, 2008                  | 

---
<PAGE>
                                                                    EXHIBIT 31.2

                                 CERTIFICATIONS

I, Fred B. Beilstein, certify that:

1.   I have reviewed this Annual Report on Form 10-K/A of AFC Enterprises, Inc.;

2.   Based on my knowledge, this report does not contain any untrue statement of
a material fact or omit to state a material fact necessary to make the
statements made, in light of the circumstances under which such statements were
made, not misleading with respect to the period covered by this report;

3.   Based on my knowledge, the financial statements, and other financial
information included in this report, fairly present in all material respects the
financial condition, results of operations and cash flows of the registrant as
of, and for, the periods presented in this report;

4.   The registrant's other certifying officer and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

     a) Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under our supervision, to
ensure that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being prepared;

     b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

     c) Disclosed in this report any change in the registrant's internal control
over financial reporting that occurred during the registrant's fourth fiscal
quarter that has materially affected, or is reasonably likely to materially
affect, the registrant's internal control over financial reporting; and

5.   The registrant's other certifying officer and I have disclosed, based on
our most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent functions):

     a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and

     b) Any fraud, whether or not material, that involves management or other
employees who have a significant role in the registrant's internal control over
financial reporting.


Date:  May 24, 2004



/s/ Fred B. Beilstein
---------------------
Fred B. Beilstein
Chief Financial Officer
MAGISTRATE JUDGE'S MINUTES 

IN THE UNITED STATES DISTRICT COURT 

DISTRICT OF ARIZONA – TUCSON 

U.S. Magistrate Judge: Bruce G. Macdonald Date: January 18, 2018 

USA v. Scott Daniel Warren Case Number: 18-01455MJ-001-TUC-BPV

U.S. Attorney: Beverly Anderson (duty)

Interpreter: Clark Feaster Language: Spanish 

Material Witness(es) 

1 - Kristian Perez-Villanueva; 2 - Jose Arnaldo Sacaria-Goday 

Material Witness(es) state true name(s) to be 

1 - Kristian Gerardo Perez-Villanueva; 2 - SAME 

Material Witness(es): ☒ Present ☐ Not Present ☐ Released 

☒ Custody ☐ Summons ☐ Writ 

 Restraint Level 0 

INITIAL APPEARANCE – MATERIAL WITNESS(ES) 

☒ Complaint Filed Date of Arrest: January 17, 2018 

☐ Warrant Other District ☐ Financial Affidavit taken ☐ NO Financial Affidavit taken 

☐ Counsel waives reading of the Complaint/Indictment 

☒ An Attorney is appointed to represent the material witness(es). 

☒ Upon questioning of the alleged material witness(es), the Court finds that they are not citizens of 

the United States. 

☒ Material Witness(es) shall be temporarily detained in the custody of the United States Marshal 

pursuant to ☒ 18§ 3142(f) ☐ 18§ 3142(d) 

 IT IS ORDERED: within 48 hours of this Order*, that the United States Attorney shall 

schedule a date and time within 30 days of this Order for videotaping of the material witnesses and 

shall file within 48 hours of this Order* notice of the date and time of said taping and the name of 

each material witness to be videotaped. *IN THE CASE OF A JUVENILE MATERIAL WITNESS, 

WITHIN 24 HOURS OF THIS ORDER. 

 IT IS ORDERED that counsel raising objections during the video depositions must (1) note the 

time and place on the videotape wherein the objection arose, (2) raise the objection before the district 

court in a short pleading filed no later than the deadline for the filing of Motions in the matter, (3) be 

prepared to roll the videotape at the exact point of any/all objections at the Motions hearing. 

OTHER: The Government has filed notice for the depositions to take place on 2/9/18 @ 8:30 AM in 

the Grand Jury Room. 

Recorded By Courtsmart

Deputy Clerk Beth Harper 

MW/IA 5 min 

Start: 1:15 pm 

Stop: 1:20 pm 

Case 4:18-cr-00223-RCC-DTF Document 9 Filed 01/18/18 Page 1 of 1
# United States Court **of Appeals**  **f or the Fifth Circuit** 

**____________** No. 23

- 10748 Summary Calendar

**____________ United States of America,**  Plaintiff

— Appellee **,**

versus **Willie Roy Wilson, III,** Defendant

— Appellant

**.**

**______________________________** Appeal from the United States District Court for the Northern District of Texas USDC No. 2:22

- CR

- 83

- 1

**_______________ _______________**  Before **Elrod, Oldham,** and **Wilson,** Circuit Judges

**. Per Curiam**  **:** *****
The Federal Public Defender appointed to represent Willie Roy Wilson, III, has moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Wilson has filed a response. The record is not sufficiently developed to all ow us to make a fair evaluation of

**_____________________**

* This opinion is not designated for publication. See **5th Cir**

**. R** 

**.** 47.5. United States Court of Appeals Fifth Circuit 

### FILED March 7, 2024 Lyle W. Cayce Clerk Case: 23-10748 Document: 46-1 Page: 1 Date Filed: 03/07/2024No. 23

- 10748

2 Wilson ’s claim of ineffective assistance of counsel; we therefore decline to consider the claim without prejudice to collateral review. See United States v. Isgar , 739 F.3d 829, 841 (5th Cir. 2014). We have reviewed counsel’s brief and the relevant portions of the record reflected therein, as well as Wilson ’s respon se. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, the motion for leave to withdraw is **GRANTED** , counsel is excused from further responsibilities herein, and the appeal is **DISMISSED**

. See **5th Cir. R**

. 42.2. Case: 23-10748 Document: 46-1 Page: 2 Date Filed: 03/07/2024
H. Res. 757 

In the House of Representatives, U. S., 

September 30, 2009. 

Whereas homicide is a devastating epidemic in this Nation, 

destroying families and communities; 

Whereas women are disproportionately victims of homicide 

perpetrated by intimate partners; 

Whereas intimate partner homicide is the leading cause of 

death for African-American women ages 15–45; 

Whereas, on average, 3 women per day are murdered by their 

current or former husbands or partners and the Centers 

for Disease Control and Prevention finds that women experience 2,000,000 injuries from intimate partner violence each year; 

Whereas according to the Centers for Disease Control and 

Prevention, the cost of intimate partner violence exceeded 

$5,800,000,000 in 2003; 

Whereas, for the years 1976 to 2005 combined, among all 

homicide victims, females were particularly at risk for intimate killings and sex-related homicides, with 64.8 percent of all female homicide victims during that time being 

murdered by an intimate partner; 

Whereas one-third of all murdered females are victims of intimate partner homicide annually, with separated females 

having the highest homicide rate; 
2 

•HRES 757 EH 

Whereas intimate partner violence resulted in 1,544 deaths in 

2004, and of those deaths, 25 percent were males and 75 

percent were females; 

Whereas the time that a victim of domestic violence leaves a 

violent situation is the most dangerous time for a victim 

and increases his or her likelihood of becoming a victim 

of homicide; 

Whereas homicide is the second leading cause of traumatic 

death for pregnant women and recently pregnant women, 

accounting for nearly 31 percent of maternal injury 

deaths; 

Whereas numerous agencies across this country provide support to the families of homicide victims and the tireless 

work of agency staff and volunteers is worthy of acknowledgment; and 

Whereas victims of domestic violence-related homicides should 

be remembered during the National Day of Remembrance 

for Homicide Victims to honor their memories: Now, 

therefore, be it 

Resolved, That the House of Representatives— 

(1) supports the goals and ideals of a National Day 

of Remembrance for Homicide Victims; and 

(2) acknowledges the epidemic of intimate partner 

homicide in this Nation, its disproportionate impact on 

women, and the work of agencies across this country to 

address this epidemic and provide support and resources 
3 

•HRES 757 EH 

to all survivors of victims of homicide, including the families of intimate partner homicide. 

Attest: 

Clerk.
1

In The

Court of Appeals

Ninth District of Texas at Beaumont

_________________

NO. 09-18-00420-CV

_________________

TRACEY DENBY, Appellant

V.

JOSEPH HERMAN, Appellee

________________________________________________________________________

On Appeal from the 172nd District Court

Jefferson County, Texas

Trial Cause No. E-201,324

________________________________________________________________________

ORDER

On March 28, 2019, we dismissed this appeal for want of prosecution. See 

Tex. R. App. P. 37.3(b), 42.3(b). On April 29, 2019, the appellant, Tracey Denby, 

filed a motion for extension of time to file a motion for rehearing. We granted the

motion for extension of time and the appellant filed a motion for rehearing. See Tex. 

R. App. P. 49.1, 49.8. The appellee, Joseph Herman, filed a response to the motion 

for rehearing. See Tex. R. App. P. 49.2.
2

The motion for rehearing filed by the appellant is granted. See Tex. R. App. 

P. 49.3. We withdraw our Opinion of March 28, 2019, and the judgment entered 

thereon on the same date. We reinstate the appeal on the Court’s docket. The brief 

of the appellant, received May 6, 2019, is filed. The brief of the appellee is due 

Friday, June 21, 2019. 

ORDER ENTERED May 20, 2019.

PER CURIAM

Before McKeithen, C.J., Kreger, and Johnson, JJ.
United States Court of Appeals

for the Fifth Circuit ____________

No. 22-10871

Summary Calendar

____________

United States of America, 

Plaintiff—Appellee,

versus

Luis Adrian Amaro-Lopez, 

Defendant—Appellant.

______________________________

Appeal from the United States District Court 

for the Northern District of Texas

USDC No. 5:17-CR-107-1

______________________________

Before Elrod, Willett and Ho, Circuit Judges.

Per Curiam:*

Luis Adrian Amaro-Lopez, federal prisoner # 03649-408, moves for 

leave to proceed in forma pauperis (IFP) in his appeal from the denial of his 

18 U.S.C. § 3582(c)(1)(A)(i) motion for compassionate release. He is 

currently serving a 168-month sentence for distribution and possession with 

intent to distribute 50 grams or more of methamphetamine. The district 

court determined that Amaro-Lopez failed to show extraordinary and 

_____________________

* This opinion is not designated for publication. See 5th Cir. R. 47.5.

United States Court of Appeals

Fifth Circuit

FILED

December 30, 2022

Lyle W. Cayce

Clerk

Case: 22-10871 Document: 00516593495 Page: 1 Date Filed: 12/30/2022
No. 22-10871

2

compelling reasons warranting relief and that the 18 U.S.C. § 3553(a) factors 

did not weigh in favor of relief. See § 3582(c)(1)(A)(i). 

In his brief on appeal, Amaro-Lopez contends that the district court 

abused its discretion in denying his motion for compassionate release because 

it failed to address his arguments and failed to articulate any reasons for the 

denial of his motion. In his compassionate release motion, Amaro-Lopez 

argued that the following circumstances presented extraordinary and 

compelling circumstances for compassionate release: (i) his sister suffered 

from diabetes and other medical issues that prevented her from properly 

administering her medication, and he was needed as her primary caregiver; 

(ii) the conditions at his prison facility were “harsh” due to effects of 

COVID-19; (iii) he was denied the opportunity to earn time credits under 18 

U.S.C. § 3632(d)(4), because he did not speak English and no educational 

programs were being offered at his correctional facility due to COVID-19; 

and (iv) he was sentenced using the multiplier for actual methamphetamine 

instead of that for a methamphetamine mixture and the purity distinction 

between the multipliers is arbitrary and unjust. Amaro-Lopez fails to identify 

a nonfrivolous argument that an extraordinary or compelling circumstance 

justified the granting of his compassionate release motion. See United States 

v. Jackson, 27 F.4th 1088, 1093 n.8 (5th Cir. 2022); United States v. 

Chambliss, 948 F.3d 691, 693-94 (5th Cir. 2020). 

Accordingly, his IFP motion is DENIED, and the appeal is 

DISMISSED as frivolous. See Baugh v. Taylor, 117 F.3d 197, 202 & n.24 

(5th Cir. 1997); Howard v. King, 707 F.2d 215, 220 (5th Cir. 1983); 5th 

Cir. R. 42.2.

Case: 22-10871 Document: 00516593495 Page: 2 Date Filed: 12/30/2022
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEET AT DECEMBER 31, 1998 AND THE STATEMENT OF OPERATIONS FOR THE YEAR ENDED
DECEMBER 31, 1998 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               DEC-31-1998
<CASH>                                      19,986,107
<SECURITIES>                                         0
<RECEIVABLES>                                1,104,086
<ALLOWANCES>                                   184,875
<INVENTORY>                                  3,240,869
<CURRENT-ASSETS>                            24,578,765
<PP&E>                                       3,889,090
<DEPRECIATION>                               1,126,095
<TOTAL-ASSETS>                              30,026,135
<CURRENT-LIABILITIES>                        2,384,965
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       127,299
<OTHER-SE>                                  26,719,575
<TOTAL-LIABILITY-AND-EQUITY>                26,846,874
<SALES>                                      4,769,686
<TOTAL-REVENUES>                             4,769,686
<CGS>                                        2,982,198
<TOTAL-COSTS>                                2,982,198
<OTHER-EXPENSES>                            12,055,971
<LOSS-PROVISION>                               102,000
<INTEREST-EXPENSE>                              20,667
<INCOME-PRETAX>                             (9,090,072)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                         (9,090,072)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (9,090,072)
<EPS-PRIMARY>                                    (0.72)
<EPS-DILUTED>                                    (0.72)
        

</TABLE>
*Pursuant to 5TH CIR. R. 47.5, the Court has determined that

this opinion should not be published and is not precedent except

under the limited circumstances set forth in 5TH CIR. R. 47.5.4.

UNITED STATES COURT OF APPEALS

for the Fifth Circuit

_____________________________________

No. 97-40735

_____________________________________

STEPHEN A. HODGSON,

Plaintiff-Appellee,

VERSUS

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON, ET AL.,

Defendants,

UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON,

Defendant-Appellant.

______________________________________________________

Appeal from the United States District Court

for the Southern District of Texas

(G-95-CV-612)

______________________________________________________

September 8, 1998

Before REAVLEY, DAVIS and DUHÉ, Circuit Judges.

PER CURIAM:*

AFFIRMED. See 5th Cir. R. 47.6.
2
EX-10.47 AMEND. NO. 1 TO THE DEFERRED COMP. PLAN





Exhibit
10.47



AMENDMENT NO. 1

TO THE

TIME WARNER INC.

DEFERRED COMPENSATION PLAN

(Amended and Restated as of January 1, 2005)





	1.	 	The last sentence of Section 1.3 shall be amended to read in its entirety as follows:
	 
	 	 	All amounts deferred under the Plan on or prior to December 31, 2004 shall remain subject
to the terms of the Plan as in effect on October 3, 2004, except that any such amount with
respect to which there has been a material modification as determined under Section 885
(d)(2) of the American Jobs Creation Act of 2004 and Treas. Reg. § 1.409A-6(a)(4) shall
instead be subject to the provisions of this January 1, 2005 restatement of the Plan.
	 
	2.	 	This Amendment shall be effective as of January 1, 2005.
EXHIBIT 32.1





CERTIFICATION OF CHIEF FINANCIAL OFFICER



Pursuant to 18 U.S.C. Section 1350,

As adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002



I, Simon Brewer, certify, to my best knowledge and belief, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Predictive Technology Group, Inc. on Form 10-Q for the quarter ended March 31, 2019, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of Predictive Technology Group, Inc.



|             |     |                                                                                             
|------------ | --- | --------------------------------------------------------------------------------------------
|             | By: | /s/ Simon Brewer                                                                            
|May 20, 2019 |     | Simon Brewer
Chief Accounting Officer
(Principal Accounting and Principal Financial Officer)
[Federal Register Volume 61, Number 119 (Wednesday, June 19, 1996)]
[Notices]
[Pages 31109-31110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-15615]



-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY
[FRL-5522-7]


Strategic Plan for the Office of Research and Development

AGENCY: Environmental Protection Agency.

ACTION: Correction--Notice of Availability.

-----------------------------------------------------------------------

SUMMARY: On June 7, 1996 EPA announced the availability of the 
Strategic Plan for the Office of Research and Development (EPA-600/R-
96/059), prepared by the U.S. Environmental Protection Agency's (EPA) 
Office of Research and Development (ORD). The Federal Register Notice 
(61 FR 29099) contained an incorrect phone number for interested 
parties to obtain a copy of the Strategic Plan. The correct phone 
number is (513) 569-7562, or you may fax your request to (513) 569-
7566. The Strategic Plan describes the process and criteria for 
selecting ORD's high priority research and defines the foundation for 
ORD's management and budget planning process.

DATES: The Strategic Plan for the Office of Research and Development 
was made available to the public on June 7, 1996. Interested parties 
can now access the Executive Summary of the Plan or the entire Plan via 
the Internet on the ORD Home Page (http://www.epa.gov/ORD).

ADDRESSES: The document is available for inspection at the EPA 
Headquarters Library, Waterside Mall, 401 M Street SW., Washington, DC. 
EPA Library hours are 10 a.m. to 2 p.m., Monday

[[Page 31110]]

through Friday, excluding holidays. Interested parties can obtain a 
single copy of the Strategic Plan by contacting: ORD Publications 
Office, Technology Transfer Division, National Risk Management Research 
Lab, U.S. Environmental Protection Agency, 26 W. Martin Luther King 
Drive, Cincinnati, OH 45268; Telephone: (513-569-7562) or facsimile: 
(513) 569-7566. Please provide your name and mailing address, and 
request the document by the title and EPA Document No. (EPA-600/R-96/
059). A limited number of paper copies will be available from this 
source, and requests will be filled on a first come-first served basis. 
After the supply is exhausted, copies of the Strategic Plan can be 
purchased from the National Technical Information Service (NTIS) by 
calling (703) 487-4650 or sending a facsimile to (703) 321-8547. The 
NTIS order number for the Strategic Plan is (PB96-175385.)

FOR FURTHER INFORMATION CONTACT: Sherry Hawkins, Office of Research and 
Science Integration, (8104), U.S. Environmental Protection Agency, 
Washington, D.C. 20460. Telephone (202) 260-5593; Facsimile (202-260-
0106.)

    Dated: June 13, 1996.
Dorothy E. Patton,
Director, Office of Research and Science Integration.
[FR Doc. 96-15615 Filed 6-18-96; 8:45 am]
BILLING CODE 6560-50-P